Restoring confidence in vaccines by explaining vaccine safety monitoring: Is a targeted approach needed?

Drug Safety

Volumn 29, Issue 12, 2006, Pages 1105-1109

  Casiday, Rachel E ^a   Cox, Anthony R ^b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; VACCINE;

ANXIETY DISORDER; AWARENESS; CHILD HEALTH CARE; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; FATALITY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; IMMUNITY; IMMUNIZATION; MEASLES; MUMPS; PARENTAL BEHAVIOR; PERTUSSIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; RUBELLA; SIDE EFFECT; UNITED KINGDOM; VACCINATION; VACCINATION REACTION;

CHILD; HEALTH EDUCATION; HUMANS; MASS IMMUNIZATION; PARENTS; PRODUCT SURVEILLANCE, POSTMARKETING; VACCINES;

EID: 33845410482     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200629120-00002     Document Type: Review

References (22)

1. Rawlins MD. Trading risk for benefit. In: Mann RD, ed. Risk and consent to risk in medicine. Lancs: Parthenon Publishing Group, 1989: 202
2. Hazel L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29 (5): 385-96
3. Baker JP. The pertussis vaccine controversy in Great Britain, 1974-1986. Vaccine. 2003; 21: 4003-10
4. Elliman D, Bedford H. MMR vaccine: the continuing saga. BMJ 2001 27 January; 322: 183-4
5. Wakefield A, Murch S, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41
6. Murch SH, Anthony A, Casson DH, et al. Retraction of an interpretation. Lancet 2004; 363 (9411): 750
7. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002; 347 (19): 1477-82
8. Afzal MA, Ozoemena LC, O'Hare A, et al. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol 2006 May; 78 (5): 623-30
9. D'Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autistic spectrum disorder. Pediatrics 2006: 118 (4): 1664-75
10. Lewis J, Speers T. Science and society: misleading media reporting? The MMR story. Nat Rev Immunol 2003; 3 (11): 913-8
11. Casiday R, Cresswell T, Panter-Brick C, et al. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 2006; 24 (2): 177-84
12. Bedford H, Elliman D. MMR: the onslaught continues. BMJ 2003 29 March; 326: 718
13. Alfredsson R, Svensson E, Trollfors B, et al. Why do parents hesitate to vaccinate their children against measles, mumps and rubella? Acta Paediatrica 2004 Sep; 93 (9): 1232-7
14. Gellatly J, McVittie C, Tiliopoulos N. Predicting parents' decisions on MMR immunisation: a mixed method investigation. Fam Pract 2005 Dec; 22 (6): 658-62
15. Casiday R. Risk conceptualisation, trust and decision-making in the face of contradictory information: the case of MMR. Durham: University of Durham, 2005
16. Egberts TCG, Smulders M, deKoning FHP, et al. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ 1996 Aug; 313 (7056): 530-1
17. Medawar C, Herxheimer A, Bell A, et al. Paroxetine, panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing surveillance. International Journal of Risk & Safety in Medicine 2002; 15: 161-9
18. MHRA. Report of an independent review of access to the Yellow Card scheme [online]. Available from URL: http://www.mhra.gov.uk/home/groups/comms-ic/ documents/web-detectasiteresources/con2015008.pdf [Accessed 2006 Oct 17]
19. Ekins-Daukes S, Irvine D, Wise L, et al. The Yellow Card scheme: evaluation of patient reporting of suspected adverse drug reactions. Pharmacoepidemiol Drug Saf 2006; 15 (Suppl. 1): S105
20. van Grootheest K, de Jong-van den Berg L. Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf 2004; 3 (4): 363-8
21. Henderson M. Doctor's drug ignorance putting lives at risk. Home News. The Times 2006 Jul 19
22. Cox AR, Marriott JF, Wilson KA, et al. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther 2004; 29: 31-5